Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy and safety of Metformin Glycinate versus
Metformin Hydrochloride in metabolic control and inflammatory mediators in Mexican type 2
diabetes patients, in a 12 months follow up.